Navigation Links
Wireless Device Can Cut Heart Failure-Related Hospitalizations
Date:2/10/2011

By Steven Reinberg
HealthDay Reporter

WEDNESDAY, Feb. 9 (HealthDay News) -- Researchers report that a wireless implanted device monitors fluid build-up in the lungs of heart failure patients and alerts doctors when intervention is needed.

As a result, the device reduces hospitalizations and improves quality of life for these patients, they added.

"It is the build-up of fluid pressure in the lungs that causes symptoms such a shortness of breath and leads to fluid leaking into the lung, which is the major cause of hospitalization in heart failure patients," explained study author Dr. William T. Abraham, director of the division of cardiovascular medicine at Ohio State University Medical Center in Columbus.

By monitoring the fluid pressure in the lungs, the doctor can adjust the patient's medication to bring the pressure levels down and keep the patient out of the hospital, he noted.

"This promises to revolutionize the way we manage patients who have moderate or severe heart failure," Abraham said. "Prior to this, the tools that we could use to evaluate how heart failure patients were doing were not very revealing and so we have failed to keep patients out of the hospital."

The report is published in the Feb. 9 online edition of The Lancet.

For the study, Abraham's group randomly assigned 550 patients with moderately severe heart failure to have the device implanted or not, in addition to standard medical care.

The device is placed in the pulmonary artery in the lung using a catheter, so the procedure is minimally invasive, Abraham added.

During the first six months, 83 patients with devices were hospitalized for heart failure-related problems, compared with 120 patients who did not have the device, the researchers found. That's a 30 percent reduction in hospitalizations, they noted.

Over the entire 15 months of follow-up, those with the device had a 39 percent reduction in hospitalizations, compared with those who didn't, Abraham's team found.

Data from the device is picked up by an antenna outside the body that sends the information to physicians and also keeps the device powered, Abraham said.

The device has not yet been approved by the U.S. Food and Drug Administration, Abraham noted, but it is undergoing the approval process now.

If approved, it is expected to cost about $15,000, Abraham said. "A single hospitalization for heart failure costs somewhere in the neighborhood of $12,000 to $14,000. So, just avoiding one hospitalization can make this cost-effective," he said.

Moreover, patients seem to like the device, Abraham noted: "One of our patients said they felt like we were always watching them and it gives them a sense of connectiveness to the physician and a sense of security."

Commenting on the study, Dr. Gregg Fonarow, a professor of cardiology at the University of California, Los Angeles, said that "this study represents a major advance in the management of patients with heart failure."

Heart failure results in substantial morbidity, mortality and health care expenditures, with more than 1 million hospitalizations for heart failure each year in the United States alone, he said.

"Worsening of congestion results in the majority of hospitalizations with heart failure, but traditional methods of monitoring symptoms and signs of heart failure have had limited success in preventing hospitalizations for heart failure," Fonarow said.

"Wireless implantable monitoring allows for early detection of fluid accumulation, before a patient notices changes in symptoms or weight, allowing for preemptive management to address this fluid accumulation and to prevent hospitalization for worsening heart failure," he said.

The trial was funded by CardioMEMS, the maker of the device.

More information

For more information on heart failure, visit the American Heart Association.

SOURCES: William T. Abraham, M.D., director, division of cardiovascular medicine, and professor, internal medicine, physiology and cell biology, Ohio State University Medical Center, Columbus; Gregg Fonarow, M.D., spokesman, American Heart Association, and professor, cardiology, University of California, Los Angeles; Feb. 9, 2011, The Lancet, online


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Aerohive Positioned in the “Visionaries” Quadrant of the Magic Quadrant for Wireless LAN Infrastructure
2. Mennen Medical Launches the VitaLogik 6000, a Pre-Configured Multi-Parameter Patient Monitor with New High Performance Wireless Technology
3. NHS Lincolnshire Applies Intuitive ‘Cooperative Control' Wireless LAN
4. Wireless LAN Innovator Aerohive Secures $23.5 Million Series C Investment
5. Wireless health care for diabetes
6. NHS Mid Essex Prescribes Wireless Network For New Hospital Wing
7. Framingham Public School District Selects Aerohive for its Next Generation Wireless Network
8. EnGenius Technologies, Inc. Delivers High Performance, Long Range Wireless Network to Dawson Independent School District
9. Embedded Mobile & M2M Device revenues to Rise to Almost $19 Billion Globally by 2014, Says Juniper Research
10. Scott & White Memorial Hospital uses device to revolutionize treatment of traumatic aortic injury
11. Clinical trial underway: Miniature ultrasound device could revolutionize pain relief
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Wireless Device Can Cut Heart Failure-Related Hospitalizations 
(Date:10/13/2017)... ... October 13, 2017 , ... As health professionals work to improve their ... The patient is doing more than filling out a survey; in many cases health ... increasing emphasis in health care and research on the importance of active engagement with ...
(Date:10/13/2017)... (PRWEB) , ... October 13, ... ... School of Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, ... professionals on guideline updates for the primary prevention of cardiovascular diseases during ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for professional ... action towards gender equality at their inaugural Summit in New York City in June. ... a social audience of over 3 million. To watch the Mobilize Women video, ...
(Date:10/13/2017)... ... 13, 2017 , ... “The Journey: From the Mountains to the Mission Field”: ... souls in the Philippines. “The Journey: From the Mountains to the Mission Field” is ... Bible. She has taught all ages and currently teaches a class of ladies at ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s to ... and tested to meet the highest standard. , These products are also: ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... 2017 Cohen Veterans Bioscience and Early Signal ... wearable and home sensors for real-time monitoring of patients ... a nonprofit organization focused on disruptive health solutions for ... analytical system to record and integrate behavioral, cognitive, physiological ... ...
(Date:9/25/2017)... 2017  EpiVax, Inc., a leader in the ... today announced the launch of EpiVax Oncology Inc., ... therapeutic cancer vaccines. EpiVax has provided $500,000 in ... enabling technologies to the new precision immunotherapy venture. ... Oncology as Chief Executive Officer. Gad brings over ...
(Date:9/19/2017)... Mich. , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company ... destruction of targeted tissues, announced three leadership team developments today:   ... PhD ... ... Veteran medical device executive Josh ...
Breaking Medicine Technology: